Innoviva, Inc. SEC filings INVA

Innoviva, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 27, 2012. Its latest annual report, Form 10-K, was filed on Feb 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Innoviva, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Officer or director change
May 18, 2026 May 12, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
S-8 Employee stock plan registration May 4, 2026 —
8-K Current report
Shareholder vote results
May 4, 2026 May 4, 2026
10-K/A Amended annual report Mar 27, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 24, 2026 Mar 24, 2026
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
10-K Annual report Feb 25, 2026 Dec 31, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Shareholder vote results
May 21, 2025 May 19, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 19, 2025
10-K/A Amended annual report Mar 24, 2025 Dec 31, 2024
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
UPLOAD Letter from the SEC Nov 1, 2024 —
CORRESP Letter to the SEC Sep 26, 2024 —
UPLOAD Letter from the SEC Sep 13, 2024 —
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
8-K Current report
Shareholder vote results
Jun 20, 2024 Jun 17, 2024
8-K Current report
Regulation FD disclosure
May 13, 2024 May 13, 2024
ARS Annual report to shareholders May 9, 2024 Dec 31, 2023
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report
Officer or director change
Apr 30, 2024 Apr 29, 2024
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 17, 2024
10-K/A Amended annual report Mar 22, 2024 Dec 31, 2023
10-K/A Amended annual report Mar 5, 2024 Dec 31, 2023
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
S-8 Employee stock plan registration Nov 13, 2023 —
8-K Current report
Regulation FD disclosure
Nov 6, 2023 Nov 6, 2023
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 1, 2023 Nov 1, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 25, 2023 Aug 21, 2023
8-K Current report
Listing notice
Aug 7, 2023 Aug 2, 2023
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 11, 2023 Jul 10, 2023
8-K Current report
Regulation FD disclosure
May 24, 2023 May 24, 2023
8-K Current report
Shareholder vote results
May 24, 2023 May 22, 2023
DEFA14A Additional proxy material May 17, 2023 —
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
DEFA14A Additional proxy material May 1, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
May 1, 2023 Apr 28, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 —
10-K/A Amended annual report Mar 20, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Officer or director change, Bylaw or fiscal year change
Jan 4, 2023 Jan 1, 2023
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K/A Amended current report
Acquisition or sale of assets
Oct 28, 2022 Jul 20, 2022
8-K Current report
Regulation FD disclosure
Sep 14, 2022 Sep 14, 2022
8-K Current report
Other events
Aug 23, 2022 Aug 23, 2022
8-K Current report
Acquisition or sale of assets, Other events
Aug 22, 2022 Aug 19, 2022
SC TO-T/A Filing Aug 22, 2022 —
SC TO-T/A Filing Aug 16, 2022 —
10-Q Quarterly report Jul 27, 2022 Jun 30, 2022
8-K Current report
Results of operations
Jul 27, 2022 Jul 27, 2022
SC TO-T Filing Jul 25, 2022 —
8-K Current report
Material agreement
Jul 20, 2022 Jul 20, 2022
8-K Current report
Material agreement, Other events
Jul 13, 2022 Jul 13, 2022
8-K Current report
Acquisition or sale of assets, Other events
Jul 11, 2022 Jul 7, 2022
SC TO-C Filing Jul 11, 2022 —
8-K Current report
Material agreement, Other events
Jul 11, 2022 Jul 10, 2022
425 Filing Jul 11, 2022 —
SC TO-T/A Filing Jul 8, 2022 —
CORRESP Letter to the SEC Jun 17, 2022 —
SC TO-T/A Filing Jun 17, 2022 —
SC TO-T Filing Jun 7, 2022 —
SC TO-C Filing May 24, 2022 —
SC TO-C Filing May 24, 2022 —
8-K Current report
Material agreement, Other events
May 24, 2022 May 23, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K/A Amended current report
Officer or director change
May 4, 2022 Apr 29, 2022
8-K Current report
Officer or director change
May 2, 2022 Apr 29, 2022
8-K Current report
Shareholder vote results
Apr 29, 2022 Apr 25, 2022
8-K Current report
Results of operations
Apr 28, 2022 Apr 27, 2022
8-K Current report
Regulation FD disclosure
Apr 7, 2022 Apr 7, 2022
8-K Current report
Material agreement
Apr 1, 2022 Mar 30, 2022
DEF 14A Proxy statement Mar 25, 2022 Apr 25, 2022
8-K Current report
Auditor change
Mar 25, 2022 Mar 25, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale
Mar 21, 2022 Mar 18, 2022
10-K/A Amended annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Mar 8, 2022 Mar 7, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 9, 2022 Feb 9, 2022
8-K Current report
Regulation FD disclosure
Dec 13, 2021 Dec 13, 2021
10-Q Quarterly report Oct 27, 2021 Sep 30, 2021
8-K Current report
Results of operations
Oct 27, 2021 Oct 27, 2021
10-Q Quarterly report Jul 29, 2021 Jun 30, 2021
8-K Current report
Results of operations
Jul 28, 2021 Jul 28, 2021
8-K Current report
Material agreement
May 26, 2021 May 26, 2021
8-K Current report
Material agreement, Other events
May 20, 2021 May 20, 2021
8-K Current report
Shareholder vote results
May 20, 2021 May 14, 2021
DEFA14A Additional proxy material May 5, 2021 —
8-K Current report
Results of operations
Apr 28, 2021 Apr 28, 2021
10-Q Quarterly report Apr 28, 2021 Mar 31, 2021
DEF 14A Proxy statement Apr 2, 2021 May 14, 2021
8-K Current report
Officer or director change
Mar 10, 2021 Mar 9, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 3, 2021 Feb 3, 2021
8-K Current report
Material agreement, Other events
Dec 14, 2020 Dec 11, 2020
10-Q Quarterly report Oct 28, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 28, 2020 Oct 28, 2020
10-Q Quarterly report Jul 29, 2020 Jun 30, 2020
8-K Current report
Results of operations
Jul 29, 2020 Jul 29, 2020
8-K Current report
Results of operations
Jul 29, 2020 Jul 29, 2020
8-K Current report
Officer or director change
Jun 12, 2020 Jun 11, 2020
8-K Current report
Officer or director change
May 26, 2020 May 20, 2020
10-Q Quarterly report Apr 29, 2020 Mar 31, 2020
8-K Current report
Results of operations
Apr 29, 2020 Apr 29, 2020
8-K Current report
Shareholder vote results
Apr 28, 2020 Apr 24, 2020
DEFA14A Additional proxy material Mar 31, 2020 —
8-K Current report
Other events
Mar 31, 2020 Mar 31, 2020
DEFA14A Additional proxy material Mar 12, 2020 —
DEF 14A Proxy statement Mar 11, 2020 Apr 24, 2020
10-K/A Amended annual report Feb 21, 2020 Dec 31, 2019
10-K Annual report Feb 19, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 5, 2020 Feb 5, 2020
10-Q Quarterly report Oct 30, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 30, 2019 Oct 30, 2019
8-K Current report
Agreement ended
Sep 17, 2019 Sep 13, 2019
10-Q Quarterly report Jul 24, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 24, 2019 Jul 24, 2019
8-K Current report
Results of operations
May 1, 2019 May 1, 2019
10-Q Quarterly report May 1, 2019 Mar 31, 2019
8-K Current report
Shareholder vote results
Apr 25, 2019 Apr 24, 2019
DEFA14A Additional proxy material Mar 13, 2019 —
DEF 14A Proxy statement Mar 13, 2019 Apr 24, 2019
8-K Current report
Auditor change
Feb 28, 2019 Feb 22, 2019
10-K Annual report Feb 19, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 6, 2019 Feb 6, 2019
10-Q Quarterly report Oct 31, 2018 Sep 30, 2018
8-K Current report
Results of operations
Oct 31, 2018 Oct 31, 2018
8-K Current report
Officer or director change
Oct 4, 2018 Oct 1, 2018
8-K Current report
Officer or director change
Oct 1, 2018 Sep 26, 2018
8-K Current report
Officer or director change
Sep 11, 2018 Sep 7, 2018
8-K Current report
Officer or director change
Aug 8, 2018 Aug 3, 2018
8-K Current report
Other events
Aug 2, 2018 Aug 1, 2018
10-Q Quarterly report Jul 26, 2018 Jun 30, 2018
8-K Current report
Results of operations
Jul 26, 2018 Jul 26, 2018
8-K Current report
Officer or director change
May 23, 2018 May 18, 2018
10-Q Quarterly report May 4, 2018 Mar 31, 2018
8-K Current report
Results of operations, Shareholder vote results
Apr 26, 2018 Apr 24, 2018
8-K Current report
Other events
Apr 24, 2018 Apr 24, 2018
DEF 14A Proxy statement Mar 23, 2018 Apr 24, 2018
8-K Current report
Other events
Feb 28, 2018 Feb 28, 2018
10-K Annual report Feb 23, 2018 Dec 31, 2017
8-K Current report
Material agreement, Officer or director change
Feb 13, 2018 Feb 12, 2018
8-K Current report
Results of operations
Feb 8, 2018 Feb 8, 2018
8-K Current report
Officer or director change
Feb 7, 2018 Feb 6, 2018
8-K Current report
Other events
Jan 26, 2018 Jan 26, 2018
8-K Current report
Bylaw or fiscal year change, Other events
Jan 10, 2018 Jan 9, 2018
8-K Current report
Regulation FD disclosure
Dec 22, 2017 Dec 21, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 20, 2017 Dec 19, 2017
8-K Current report
Regulation FD disclosure
Dec 11, 2017 Dec 8, 2017
10-Q Quarterly report Nov 3, 2017 Sep 30, 2017
8-K Current report
Results of operations
Oct 25, 2017 Oct 25, 2017
8-K Current report
Other events
Sep 20, 2017 Sep 19, 2017
8-K Current report
Other events
Sep 19, 2017 Sep 18, 2017
8-K Current report
Other events
Sep 15, 2017 Sep 15, 2017
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Aug 21, 2017 Aug 18, 2017
10-Q Quarterly report Aug 8, 2017 Jun 30, 2017
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Aug 7, 2017 Aug 7, 2017
8-K Current report
Other events
Aug 2, 2017 Aug 1, 2017
8-K Current report
Other events
Aug 1, 2017 Jul 31, 2017
8-K Current report
Results of operations
Jul 26, 2017 Jul 26, 2017
8-K/A Amended current report
Shareholder vote results
Jul 21, 2017 Apr 20, 2017
8-K Current report
Officer or director change
Jun 2, 2017 Jun 2, 2017
10-Q Quarterly report May 5, 2017 Mar 31, 2017
8-K Current report
Other events
May 5, 2017 May 5, 2017
8-K Current report
Regulation FD disclosure
May 2, 2017 Apr 30, 2017
8-K/A Amended current report
Shareholder vote results
Apr 28, 2017 Apr 20, 2017
8-K Current report
Results of operations
Apr 27, 2017 Apr 27, 2017
8-K Current report
Shareholder vote results, Other events
Apr 26, 2017 Apr 20, 2017
DFAN14A Filing Apr 20, 2017 —
DFAN14A Filing Apr 20, 2017 —
DEFA14A Additional proxy material Apr 20, 2017 —
DEFA14A Additional proxy material Apr 19, 2017 —
DEFA14A Additional proxy material Apr 18, 2017 —
DFAN14A Filing Apr 18, 2017 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INVA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Burlingame, CA
SEC filer status
Large accelerated filer
SEC CIK
1080014
Former names
THERAVANCE INC (until Dec 7, 2015); ADVANCED MEDICINE INC (until Aug 2, 2000)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.